Whether or not the answer is yes, if you’re among the estimated 15.5 million people—a staggering six percent of adult Americans—who have used ridiculously profitable anti-diabetes and weight-loss drugs like Ozempic and Wegovy, it seems that’s exactly what’s being done to you.
And it’s being done without concern for hard data showing that the drugs may cause incurable blindness or devastating bone loss—even as Big Pharma cash registers continue to merrily ring.
One woman woke up blind in her left eye after having injected one dose of semaglutide.
After all, you just want to look slim and sexy, right? You want the easy way to instantly lose weight without all that tiresome dieting and exercise nonsense, correct?
Well, what if you end up blind or your bones start breaking from osteoporosis?
Will you still worry about how much you weigh when shattered leg bones won’t support you?
Will you care about how sexy you look when you can’t even see yourself in the mirror?
We ask because a shocking new University of Utah study found that semaglutide—the active ingredient in Ozempic and Wegovy—and another ingredient found in similar medications likely caused serious eye damage for at least nine people taking the drugs.
Researchers believe that the action of semaglutide in rapidly decreasing blood sugar levels brought about a condition known as nonarteritic anterior ischemic optic neuropathy (NAION), a stroke in the optic nerve that can cause irreversible loss of vision.
One woman woke up blind in her left eye after having injected one dose of semaglutide. She stopped the medication. But after resuming it two months later, she lost vision in her right eye as well.
“Between 2 to 3 percent of the US population received a prescription for one of these medications in 2023,” Dr. Bradley Katz, the study’s author, told Medical News Today. “Because so many people are using these medications, it’s critical to monitor any ill effects.”
Researchers are so concerned that they’re demanding further studies, despite the fact that semaglutide, approved by the FDA for weight loss in 2022, is already being massively sold and marketed.
“We, as well as other concerned physicians, are also asking FDA to mandate a post-marketing survey of these drugs to find the true incidence of eye complications associated with them,” Dr. Katz said. “We are in discussions with other groups around the US who want to do a more comprehensive review of these medications and potential ocular side effects.”
“The proposed mechanisms of ‘injury’ put forward by the [study’s] authors are worthy of investigation,” Dr. Howard Krauss of Providence Saint John’s Health Center said.
And it’s not the first one. Two 2024 studies from the University of Southern Denmark found that people taking semaglutide have an increased risk of developing NAION. One even found that the risk doubled if taking Ozempic.
Think Jørgensen and his Big Pharma friends give a hoot about what kind of damage these drugs do to your body?
Researchers involved in a University of Copenhagen weight-loss study last year found that, in a group of 195 adults, those who took a GLP-1 medication similar to Ozempic had “reduced hip and spine bone mineral density, when they didn’t exercise.”
So, given the seriously unanswered questions about the dangers of Ozempic and Wegovy, why would Novo Nordisk, the company that makes them, keep pushing them out on the market, backed up by smiling people in a constant stream of television ads?
Money, that’s why. Big, big money. Novo Nordisk has been rolling in moolah thanks to making and peddling Ozempic and Wegovy. In the first nine months of 2023, for example, there was more than $12 billion worth of sales, representing 52 percent of Novo Nordisk’s total revenue. Its CEO, Lars Fruergaard Jørgensen, raked in $9.9 million for the year.
Think Jørgensen and his Big Pharma friends give a hoot about what kind of damage these drugs do to your body? Think again.
A spokesman for Novo Nordisk said, “After a thorough evaluation of the studies from the University of Southern Denmark and Novo Nordisk’s internal safety assessment, Novo Nordisk is of the opinion that the benefit-risk profile of semaglutide remains unchanged.”
And so does the profitability. Novo Nordisk has been struggling to fill the increased demand for their “skinny shot,” but demand has been racing ahead of production—to the tune of 25,000 new users per week.
Without further studies, Novo Nordisk has no idea the magnitude of the harm they’re causing.
It’s becoming clearer and clearer: There’s a big risk when they sell this stuff to you, but Novo Nordisk isn’t taking that risk. You are.
Calley Means, co-founder of Truemed, an organization promoting prevention rather than pharmaceutical treatment in the pursuit of good health, said: “There’s an incentive for every obesity doctor in the country to prescribe this to 80 percent of American adults and 50 percent of teens. We have much more than 50 million obese people—50 million is well over a trillion dollars a year.”
The pattern is nothing new. Big Pharma has long since proven they don’t care what their “miracle” drugs do to you because, to them, you’re nothing but a cash crop.
Remember prescription opioids? Big Pharma pushed these pain relievers hard on American doctors and the American people, insisting they weren’t habit forming when of course they are.
In 2020 alone, over 16,000 people overdosed on prescription opioids like OxyContin, and opened the gate wide to the deadly flood of fentanyl addiction still plaguing America’s streets.
And as the bodies piled up, the corporate drug dealers kept stacking their money.
But blindness from Ozempic or Wegovy is rare, isn’t it? Maybe. But how many blinded Americans are “acceptable casualties” of Big Pharma profit machines? How many people with broken bones from osteoporosis can be categorized as “just collateral damage” for the pharmaceutical companies?
The FDA needs to take a much closer look at Ozempic and Wegovy, and Americans may need to stop looking for an instant “miracle” cure for their problems.
But one thing is for sure: Big Pharma companies pushing their drugs onto innocent, unsuspecting people must be held to account for the damage they do.
